Life Expectancy of Children with Perinatal HIV in High-Income Countries

With early diagnosis and modern antiretroviral therapy (ART), children with perinatally acquired HIV in industrialized nations now have near-normal life expectancy.

Key Advances

  • Universal prenatal HIV screening → maternal ART → vertical transmission <1%.
  • Early infant diagnosis (PCR at birth, 2–4 weeks, 4–6 months).
  • Pediatric ART initiation (within weeks of birth) → immune preservation, viral suppression.
  • Improved formulations: Palatable, once-daily, integrase inhibitor-based regimens.
  • Comprehensive care: Growth monitoring, neurocognitive support, vaccination, transition to adult care.

Outcomes

  • Survival into adulthood >95% in treated cohorts.
  • Long-term complications: metabolic (lipodystrophy, insulin resistance), bone (low BMD), renal (TDF), neurocognitive.
  • Adherence challenges in adolescence.

Global Disparity

In resource-limited settings, access to early ART remains suboptimal; mortality higher. WHO "treat all" guidelines aim to close gap.

HIV & AIDS - Related Articles